|
Volumn 133, Issue 3, 1997, Pages 387-389
|
Treating patients with melanoma with interferon [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
DACARBAZINE;
BRAIN METASTASIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG COST;
DRUG INDICATION;
DRUG TOLERANCE;
FOOD AND DRUG ADMINISTRATION;
HISTOLOGY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
LYMPH NODE METASTASIS;
MELANOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURVIVAL RATE;
|
EID: 0030934342
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.133.3.387 Document Type: Letter |
Times cited : (4)
|
References (14)
|